Healthcare
Medical simulation market set to reach $7.23b by 2030
Medical simulation market set to reach $7.23b by 2030
Forecast implies 15.6% annual growth.
4 hours ago
HKUMed achieves fertility breakthrough with repurposed kidney drug
Finerenone, a drug for chronic kidney diseases tied to type 2 diabetes, revives egg development.
5 hours ago
Health sterotypes block early preventative actions amongst Asians: AIA
Rigid beliefs discourage early health action across Asia.
6 hours ago
AI, chatbots cut nurse paperwork burdens
Hospitals are deploying barcoding and digital booking tools to relieve staffing strain.
4 days ago
SMART and NUS weaponize AI to give soft robots human-like reflexes
The system reduced tracking error by 44% to 55% under heavy disturbances.
5 days ago
$2.17b AI surge projected by 2034 amidst pursuit to end missed cancer diagnoses
Asia-Pacific drives the fastest growth.
6 days ago
China captures 49% of global drug deals in 2025 amidst lower costs, faster timelines
This is an improvement from only 6% in 2020.
6 days ago
Strong pipeline, M&A activity could trigger rapid earnings for Greater China's healthcare firms: UOB
The industry is expected to become a key international player.
India’s Bio Pharma Shakti scheme signals end of import reliance
The national initiative targets drug affordability and R&D expansion.
Affordability wall drives institutional exit from Thai healthcare stocks
Patient shift to public hospitals capped Thailand’s private healthcare growth at 3%.
Pharmacy automation devices market to reach $9.83b by 2028
Steady growth projected for global automation systems.
South Korea secures $4.2b biologics deals as advanced biopharma activity expands
Licensing, funding, and IPO activity support sector development
China commands 30% of global biopharma pipeline; drives Asia’s share to 43%
The country transitions from fast follower to global innovation frontrunner.
HSA clears cancer-detecting AI for routine hospital use
Intelligent Scopes Corp secures regulatory green light for its new bladder cancer software.
Beijing palliative care training expands as Singapore steps in
Programme to train over 1,000 healthcare professionals
Australia pharma to reach $24.5b by 2030 despite 'anniversary' price cuts
Pharmaceutical spending is driven by demand and new product launches, says BMI.
How can drugmakers adjust to tighter price controls?
Cost pressure will persist as the government curbs healthcare spending.